Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
FROM THE PUBLISHER
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Original reporting by ScienceDaily. Some articles may require a subscription.